Literature DB >> 26921370

Structural and Functional Abnormalities of the Neuromuscular Junction in the Trembler-J Homozygote Mouse Model of Congenital Hypomyelinating Neuropathy.

Alexandra N Scurry1, Dante J Heredia1, Cheng-Yuan Feng1, Gregory B Gephart1, Grant W Hennig1, Thomas W Gould2.   

Abstract

Mutations in peripheral myelin protein 22 (PMP22) result in the most common form of Charcot-Marie-Tooth (CMT) disease, CMT1A. This hereditary peripheral neuropathy is characterized by dysmyelination of peripheral nerves, reduced nerve conduction velocity, and muscle weakness. APMP22 point mutation in L16P (leucine 16 to proline) underlies a form of human CMT1A as well as the Trembler-J mouse model of CMT1A. Homozygote Trembler-J mice (Tr(J)) die early postnatally, fail to make peripheral myelin, and, therefore, are more similar to patients with congenital hypomyelinating neuropathy than those with CMT1A. Because recent studies of inherited neuropathies in humans and mice have demonstrated that dysfunction and degeneration of neuromuscular synapses or junctions (NMJs) often precede impairments in axonal conduction, we examined the structure and function of NMJs in Tr(J)mice. Although synapses appeared to be normally innervated even in end-stage Tr(J)mice, the growth and maturation of the NMJs were altered. In addition, the amplitudes of nerve-evoked muscle endplate potentials were reduced and there was transmission failure during sustained nerve stimulation. These results suggest that the severe congenital hypomyelinating neuropathy that characterizes Tr(J)mice results in structural and functional deficits of the developing NMJ.
© 2016 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Axonal degeneration; Hypomyelinating neuropathy; Myelination; Neuromuscular junction; Synaptic transmission; Terminal Schwann cell

Mesh:

Substances:

Year:  2016        PMID: 26921370      PMCID: PMC4845671          DOI: 10.1093/jnen/nlw004

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  46 in total

1.  Glial cells maintain synaptic structure and function and promote development of the neuromuscular junction in vivo.

Authors:  Linga V Reddy; Samir Koirala; Yoshie Sugiura; Albert A Herrera; Chien Ping Ko
Journal:  Neuron       Date:  2003-10-30       Impact factor: 17.173

Review 2.  Disease mechanisms in inherited neuropathies.

Authors:  Ueli Suter; Steven S Scherer
Journal:  Nat Rev Neurosci       Date:  2003-09       Impact factor: 34.870

3.  Differences in neuromuscular transmission in red and white muscles.

Authors:  R A Gertler; N Robbins
Journal:  Brain Res       Date:  1978-02-17       Impact factor: 3.252

4.  A quantitative description of end-plate currents.

Authors:  K L Magleby; C F Stevens
Journal:  J Physiol       Date:  1972-05       Impact factor: 5.182

5.  An intrinsic distinction in neuromuscular junction assembly and maintenance in different skeletal muscles.

Authors:  San Pun; Markus Sigrist; Alexandre F Santos; Markus A Ruegg; Joshua R Sanes; Thomas M Jessell; Silvia Arber; Pico Caroni
Journal:  Neuron       Date:  2002-04-25       Impact factor: 17.173

6.  Congenital hypomyelination neuropathy in a newborn infant: unusual cause of diaphragmatic and vocal cord paralyses.

Authors:  J S Hahn; M Henry; L Hudgins; A Madan
Journal:  Pediatrics       Date:  2001-11       Impact factor: 7.124

7.  Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.

Authors:  Lindsey R Fischer; Deborah G Culver; Philip Tennant; Albert A Davis; Minsheng Wang; Amilcar Castellano-Sanchez; Jaffar Khan; Meraida A Polak; Jonathan D Glass
Journal:  Exp Neurol       Date:  2004-02       Impact factor: 5.330

Review 8.  Mouse models of Charcot-Marie-Tooth disease.

Authors:  Yosuke Tanaka; Nobutaka Hirokawa
Journal:  Trends Genet       Date:  2002-12       Impact factor: 11.639

9.  Nerve conduction abnormalities in the trembler-j mouse: a model for Charcot-Marie-Tooth disease type 1A?

Authors:  Gregg D Meekins; Michael J Emery; Michael D Weiss
Journal:  J Peripher Nerv Syst       Date:  2004-09       Impact factor: 3.494

10.  Dysmyelinated lower motor neurons retract and regenerate dysfunctional synaptic terminals.

Authors:  Xinghua Yin; Grahame J Kidd; Erik P Pioro; Jennifer McDonough; Ranjan Dutta; M Laura Feltri; Lawrence Wrabetz; Albee Messing; Ryan M Wyatt; Rita J Balice-Gordon; Bruce D Trapp
Journal:  J Neurosci       Date:  2004-04-14       Impact factor: 6.167

View more
  9 in total

1.  Glycosylation Limits Forward Trafficking of the Tetraspan Membrane Protein PMP22.

Authors:  Justin T Marinko; Madison T Wright; Jonathan P Schlebach; Katherine R Clowes; Darren R Heintzman; Lars Plate; Charles R Sanders
Journal:  J Biol Chem       Date:  2021-04-29       Impact factor: 5.157

2.  A Novel Striated Muscle-Specific Myosin-Blocking Drug for the Study of Neuromuscular Physiology.

Authors:  Dante J Heredia; Douglas Schubert; Siddhardha Maligireddy; Grant W Hennig; Thomas W Gould
Journal:  Front Cell Neurosci       Date:  2016-12-01       Impact factor: 5.505

3.  Developmental demands contribute to early neuromuscular degeneration in CMT2D mice.

Authors:  James N Sleigh; Aleksandra M Mech; Giampietro Schiavo
Journal:  Cell Death Dis       Date:  2020-07-23       Impact factor: 8.469

4.  Differentiation of Human Tonsil-Derived Mesenchymal Stem Cells into Schwann-Like Cells Improves Neuromuscular Function in a Mouse Model of Charcot-Marie-Tooth Disease Type 1A.

Authors:  Saeyoung Park; Namhee Jung; Seoha Myung; Yoonyoung Choi; Ki Wha Chung; Byung-Ok Choi; Sung-Chul Jung
Journal:  Int J Mol Sci       Date:  2018-08-14       Impact factor: 5.923

5.  Identification of a new SYT2 variant validates an unusual distal motor neuropathy phenotype.

Authors:  Nataly I Montes-Chinea; Zhuo Guan; Marcella Coutts; Cecilia Vidal; Steve Courel; Adriana P Rebelo; Lisa Abreu; Stephan Zuchner; J Troy Littleton; Mario A Saporta
Journal:  Neurol Genet       Date:  2018-10-22

6.  HSP90 Inhibitor, NVP-AUY922, Improves Myelination in Vitro and Supports the Maintenance of Myelinated Axons in Neuropathic Mice.

Authors:  Vinita G Chittoor-Vinod; Hannah Bazick; Adrian G Todd; Darin Falk; Kathryn H Morelli; Robert W Burgess; Thomas C Foster; Lucia Notterpek
Journal:  ACS Chem Neurosci       Date:  2019-05-03       Impact factor: 4.418

7.  Neuromuscular Junction Changes in a Mouse Model of Charcot-Marie-Tooth Disease Type 4C.

Authors:  Silvia Cipriani; Vietxuan Phan; Jean-Jacques Médard; Rita Horvath; Hanns Lochmüller; Roman Chrast; Andreas Roos; Sally Spendiff
Journal:  Int J Mol Sci       Date:  2018-12-17       Impact factor: 5.923

8.  Disruption of genes associated with Charcot-Marie-Tooth type 2 lead to common behavioural, cellular and molecular defects in Caenorhabditis elegans.

Authors:  Ming S Soh; Xinran Cheng; Tarika Vijayaraghavan; Arwen Vernon; Jie Liu; Brent Neumann
Journal:  PLoS One       Date:  2020-04-15       Impact factor: 3.240

9.  Sam68 splicing regulation contributes to motor unit establishment in the postnatal skeletal muscle.

Authors:  Elisa De Paola; Laura Forcina; Laura Pelosi; Simona Pisu; Piergiorgio La Rosa; Eleonora Cesari; Carmine Nicoletti; Luca Madaro; Neri Mercatelli; Filippo Biamonte; Annalisa Nobili; Marcello D'Amelio; Marco De Bardi; Elisabetta Volpe; Daniela Caporossi; Claudio Sette; Antonio Musarò; Maria Paola Paronetto
Journal:  Life Sci Alliance       Date:  2020-08-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.